| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.89B | 9.83B | 5.77B | 5.36B | 7.46B | 4.28B |
| Gross Profit | 4.67B | 3.86B | 951.52M | 2.92B | 3.70B | 2.29B |
| EBITDA | 2.11B | 2.19B | 1.13B | 1.04B | 1.96B | 1.04B |
| Net Income | 1.32B | 1.39B | 563.31M | 575.54M | 1.25B | 542.73M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 25.87B | 19.25B | 11.34B | 9.94B | 7.87B |
| Cash, Cash Equivalents and Short-Term Investments | 676.99M | 393.97M | 498.13M | 455.23M | 1.08B | 1.04B |
| Total Debt | 0.00 | 10.82B | 6.81B | 250.00M | 730.65M | 0.00 |
| Total Liabilities | -12.10B | 13.77B | 8.93B | 1.57B | 1.82B | 916.68M |
| Stockholders Equity | 12.10B | 10.33B | 9.05B | 8.58B | 8.12B | 6.96B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -4.62B | -6.55B | -1.21B | -241.14M | 1.07B |
| Operating Cash Flow | 0.00 | 429.43M | -382.55M | 2.95B | 29.98M | 1.16B |
| Investing Cash Flow | 0.00 | -4.56B | -6.07B | -4.14B | -610.15M | -84.08M |
| Financing Cash Flow | 0.00 | 4.03B | 6.50B | 570.24M | 599.07M | -987.74M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | ₹77.59B | 18.86 | ― | 1.18% | 8.84% | 41.74% | |
67 Neutral | ₹17.10B | 15.47 | ― | 0.28% | 34.25% | 28.44% | |
66 Neutral | ₹23.44B | 40.00 | ― | 0.42% | 7.76% | -21.05% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ₹47.84B | 30.71 | ― | ― | 22.27% | 7.09% | |
53 Neutral | ₹30.88B | 33.08 | ― | 0.27% | 20.41% | -6.50% | |
40 Underperform | ₹78.70B | -11.55 | ― | ― | -20.02% | 25.52% |
Kitex Garments Limited has submitted to the stock exchanges a compliance certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2025. The company’s Registrar and Transfer Agent, Cameo Corporate Services Limited, confirmed that all dematerialization requests received during the quarter were processed within the prescribed timelines, with corresponding securities duly mutilated, cancelled, and credited in demat form, indicating adherence to regulatory norms and supporting confidence in the company’s share transfer and demat processes for investors and regulators.